Axogen Inc vs JPMorgan Ultra Short Income ETF — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while JPMorgan Ultra Short Income ETF trades at $50.45. The key difference: Axogen Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | JPST | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $48.48 | $50.78 |
52-Week Low | $14.16 | $50.40 |
Enterprise Value | $2.52B | — |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →